Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing atomoxetine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Strattera |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atomoxetine (as atomoxetine hydrochloride) 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atomoxetine (as atomoxetine hydrochloride) 18 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 25 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Strattera 10mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Strattera 18mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Strattera 25mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Strattera 40mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Strattera 60mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atomoxetine hydrochloride (substance) |
Is a |
False |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 80 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atomoxetine (as atomoxetine hydrochloride) 100 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atomoxetine (as atomoxetine hydrochloride) 10 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atomoxetine (as atomoxetine hydrochloride) 18 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 60 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atomoxetine (as atomoxetine hydrochloride) 100 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 80 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing atomoxetine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atomoxetine hydrochloride (substance) |
Is modification of (attribute) |
True |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atomoxetine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atomoxetine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atomoxetine (as atomoxetine hydrochloride) 4 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Atomoxetine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |